Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Change in Cash (2020 - 2025)

Historic Change in Cash for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $2.2 million.

  • iSpecimen's Change in Cash rose 64933.49% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 20631.01%. This contributed to the annual value of -$465258.0 for FY2024, which is 9641.14% up from last year.
  • Per iSpecimen's latest filing, its Change in Cash stood at $2.2 million for Q3 2025, which was up 64933.49% from -$193788.0 recorded in Q2 2025.
  • iSpecimen's Change in Cash's 5-year high stood at $17.9 million during Q4 2021, with a 5-year trough of -$11.5 million in Q1 2023.
  • Over the past 5 years, iSpecimen's median Change in Cash value was -$377902.0 (recorded in 2023), while the average stood at $109834.2.
  • Over the last 5 years, iSpecimen's Change in Cash had its largest YoY gain of 696785.53% in 2021, and its largest YoY loss of 88848.22% in 2021.
  • Over the past 5 years, iSpecimen's Change in Cash (Quarter) stood at $17.9 million in 2021, then tumbled by 129.8% to -$5.3 million in 2022, then surged by 92.94% to -$377902.0 in 2023, then surged by 133.49% to $126554.0 in 2024, then surged by 1633.63% to $2.2 million in 2025.
  • Its Change in Cash was $2.2 million in Q3 2025, compared to -$193788.0 in Q2 2025 and -$1.1 million in Q1 2025.